SCHEMBL6162767

SCHEMBL6162767

Fc1ccc(Cc2ccccc2N2CCN(C/C=C/c3ccccc3)CC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.56
LMNA P02545 5/20 0.56
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
MAPK1 P28482 4/20 0.56
CYP2D6 P10635 3/20 0.56
OPRM1 P35372 3/20 0.56
HIF1A Q16665 2/20 0.56
CYP1A2 P05177 2/20 0.56
CYP3A4 P08684 2/20 0.56
CYP2C9 P11712 2/20 0.56
SIGMAR1 Q99720 2/20 0.56
SLC6A4 P31645 2/20 0.56
SLC6A3 Q01959 2/20 0.56
THPO P40225 1/20 0.56
CACNA1G O43497 1/20 0.56
CACNA1H O95180 1/20 0.56
CHRM2 P08172 1/20 0.56
CHRM4 P08173 1/20 0.56
HTR1A P08908 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6162772 1.00 MAPT (0.56) MAPTLMNAMEN1KMT2AMAPK1
SCHEMBL6161962 0.91 ALDH1A1 (0.59) MAPTLMNAMEN1KMT2AMAPK1
SCHEMBL6161973 0.91 ALDH1A1 (0.59) MAPTLMNAMEN1KMT2AMAPK1
SCHEMBL16226546 0.80 KDM4E (0.68) MAPTLMNAMEN1KMT2AMAPK1
SCHEMBL16226547 0.80 KDM4E (0.68) MAPTLMNAMEN1KMT2AMAPK1
SCHEMBL6161037 0.79 MEN1 (0.54) MAPTLMNAMEN1KMT2AMAPK1
SCHEMBL6161035 0.79 MEN1 (0.54) MAPTLMNAMEN1KMT2AMAPK1
SCHEMBL2009645 0.78 LMNA (0.51) MAPTLMNAMEN1KMT2AMAPK1
SCHEMBL2009647 0.78 LMNA (0.51) MAPTLMNAMEN1KMT2AMAPK1
SCHEMBL6160266 0.77 LTA4H (0.55) MAPTLMNAMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0755923-B1 Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor DAIICHI SUNTORY PHARMA CO LTD (JP) 2005-05-04 EP disclosed
US-6469010-B1 COMPOSITION ALSO FOR ALLEVIATION OR TREATMENT OF SYMPTOMS DERIVED FROM SEIZURES, EPILEPSY AND MIGRAINE HEADACHES, AND SUPPRESSION OF CALCIUM ION OVERLOAD SUNTORY LIMITED (JP) 2002-10-22 US disclosed
US-6048876-A ANTICONVULSANTS; ANTIEPILEPIC AGENT SUNTORY LIMITED (JP) 2000-04-11 US disclosed
EP-0755923-A1 AMELIORANT OR REMEDY FOR SYMPTOMS CAUSED BY ISCHEMIC DISEASES AND COMPOUNDS USEFUL THEREFOR SUNTORY LIMITED (JP) 1997-01-29 EP disclosed